Become A Featured Company

Signal Bay (SGBY) Builds Presence in $850 Million Cannabis Testing Industry

Ryan Allway

June 8th, 2016

News, Top Story

Signal Bay Inc. (OTC Pink: SGBY), a leading provider of cannabis consulting, licensing, compliance, and laboratory services, has been actively building its presence in the $850 million cannabis testing industry. After already capturing about 75% of Oregon’s market, the company plans to extend its reach to include all of the state’s market before moving on to Northern California’s Emerald Triangle – the largest cannabis producing region in the U.S.

In this article, we will take a detailed look at the company’s expansion plans and where the stock may be headed over the coming quarters.

Covering All of Oregon’s Market

Signal Bay recently announced the acquisition of a majority stake in Kenevir Research of Medford, Oregon – a top 100 private cannabis company in Ackrell Capital’s industry report – following its acquisition of Oregon Analytical Services on May 25 and the spin-out of EVIO Labs on April 20 to focus on the testing vertical. The acquisition puts EVIO Labs in reach of 75% of the Oregon cannabis marketplace – making it the largest player in the space – and complements its existing Eugene and Bend laboratory presence.

Over the coming months, the company plans to identify a prospective location in the Portland metropolitan area in order to provide cannabis lab testing services to 100% of the Oregon cannabis market place and generate an estimated $10 million in annual testing revenue. With a market capitalization of about $475,000, the generation of such a significant amount of added revenue could translate to a much higher share price.

Oregon is expected to generate about $43 million in tax revenue from recreational cannabis this year, which is sharply higher than its original estimates of just $2-3 million for the year. The state’s Liquor Control Commission is worried that there is a lack of marijuana testing laboratories in the pipeline for licensing given the surging demand for the drug. As of October 1, 2016 there will be increasing testing requirements going into effect which should lead to increased revenues for laboratories operating in the state.

Moving into the Emerald Triangle

Signal Bay announced a letter of intent to expand its cannabis testing services to the Emerald Triangle in Northern California earlier this year. Under the terms of the agreement, the company will operate a cannabis testing laboratory and provide analytical testing services to the largest cannabis producing region in the U.S. Management hopes to leverage its expertise in Oregon to provide immediate value in these regions as testing becomes a necessity.

The move marks the company’s expansion into the Western United States, where cannabis legalization has built a robust foothold. In addition to California and Oregon, Colorado represents the first state to have legalized recreational marijuana and Nevada could soon become a leading cannabis tourist destination. These markets have become considerably larger than Central and Eastern states so far as they have embraced legalization.

In addition to being the largest cannabis producing region in the U.S., California’s cannabis market is the largest in the country at $1.3 billion per year. The company believes that the California cannabis testing market would exceed $80 million per year with the passing of a recreational ballot initiative in November 2016. The recent passing of AB 243, AB 266, an SB 643 also highlight the demand for independent testing to ensure safety for MMJ patients.

Potential Bottom Line Impact

GreenWave Advisors believes that cannabis testing is the most attractive subset of the industry with the potential to reach $850 million in size by 2020. With cannabis remaining federally illegal, cannabis testing represents a lower risk subset of the industry that is driven by a growing number of statewide regulations and demand for safe product from consumers. These services also tend to command a relatively high profit margin with high barriers to entry.

Signal Bay trades with a market capitalization of about $475,000, which represents a fraction of its potential and is significantly below many of its industry peers:

Ticker Market Cap Revenue (Latest Q) P/S Ratio
DIGP $4.15 M $141,000 N/A
MYDX $3.78 M $161,000 6.93x
CANL $12.53 M $470,000 12.32x
SGBY $475 K $171,000 0.98x

With its newly minted acquisitions, the company could experience significant revenue growth over the coming quarters. These growth rates could draw attention to the stock, which has flown largely under-the-radar of investors with just $12,000 in daily dollar volume, and eventually help move the price closer to its peer valuations. Over the long-term, the company is also likely to benefit by its growing footprint and regulatory demand for cannabis testing.

More Information

Investors interested in learning more about Signal Bay should check out the company’s website at www.signalbay.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading